Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2005-02-22
2005-02-22
Badio, Barbara P. (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
active
06858596
ABSTRACT:
There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I)or a solvate thereof.
REFERENCES:
patent: 3067197 (1962-12-01), Agnelio et al.
patent: 3639434 (1972-02-01), Oxley et al.
patent: 3828080 (1974-08-01), May et al.
patent: 3856828 (1974-12-01), Phillips et al.
patent: 3981894 (1976-09-01), Phillipps et al.
patent: 3989686 (1976-11-01), Phillipps et al.
patent: 4093721 (1978-06-01), Phillipps et al.
patent: 4187301 (1980-02-01), Edwards
patent: 4188385 (1980-02-01), Edwards
patent: 4198403 (1980-04-01), Alvarez
patent: 4261984 (1981-04-01), Alvarez
patent: 4263289 (1981-04-01), Edwards
patent: 4267173 (1981-05-01), Draper
patent: 4285937 (1981-08-01), Kalvoda
patent: 4310466 (1982-01-01), Edwards
patent: 4335121 (1982-06-01), Phillipps et al.
patent: 4377389 (1983-03-01), Phillips et al.
patent: 4472393 (1984-09-01), Shapiro
patent: 4607028 (1986-08-01), Schmidlin
patent: 4710495 (1987-12-01), Bodor
patent: 4861765 (1989-08-01), Mitsukuchi et al.
patent: 4992474 (1991-02-01), Skidmore et al.
patent: 4994439 (1991-02-01), Longenecker et al.
patent: 4996335 (1991-02-01), Bodor
patent: 5250293 (1993-10-01), Gleich
patent: 5420120 (1995-05-01), Boltralik
patent: 5658549 (1997-08-01), Akehurst et al.
patent: 5707984 (1998-01-01), Tjoeng et al.
patent: 5837699 (1998-11-01), Sequeira et al.
patent: 5849265 (1998-12-01), Li-Bovet et al.
patent: 5889015 (1999-03-01), Sequeira et al.
patent: 5919776 (1999-07-01), Hagmann et al.
patent: 5972920 (1999-10-01), Seidel
patent: 5981517 (1999-11-01), Bodor
patent: 6057307 (2000-05-01), Sequeira et al.
patent: 6127353 (2000-10-01), Yuen et al.
patent: 6136294 (2000-10-01), Adjei et al.
patent: 6197761 (2001-03-01), Biggadike et al.
patent: 6261539 (2001-07-01), Adjei et al.
patent: 6395300 (2002-05-01), Straub et al.
patent: 6537983 (2003-03-01), Biggadike et al.
patent: 20020165211 (2002-11-01), Biggadike et al.
patent: 20020173496 (2002-11-01), Biggadike
patent: 20020177581 (2002-11-01), Biggadike
patent: 2336693 (1975-02-01), None
patent: 2538569 (1977-03-01), None
patent: 0004773 (1979-10-01), None
patent: 0057401 (1982-08-01), None
patent: 0135476 (1985-03-01), None
patent: 0179583 (1986-04-01), None
patent: 0416951 (1991-03-01), None
patent: 0418716 (1991-03-01), None
patent: 0521455 (1993-01-01), None
patent: 0640616 (1995-03-01), None
patent: 0646593 (1995-04-01), None
patent: 580494 (1986-10-01), None
patent: 1384372 (1975-02-01), None
patent: 1438940 (1976-06-01), None
patent: 1517278 (1978-07-01), None
patent: 2079755 (1982-01-01), None
patent: 2140800 (1984-12-01), None
patent: 109856 (1998-02-01), None
patent: 04208267 (1992-07-01), None
patent: 9214472 (1992-09-01), None
patent: 9421229 (1994-09-01), None
patent: 9531964 (1995-11-01), None
patent: 9619199 (1996-06-01), None
patent: 9705136 (1997-02-01), None
patent: 9715296 (1997-05-01), None
patent: 9724365 (1997-07-01), None
patent: 9746243 (1997-12-01), None
patent: 9817676 (1998-04-01), None
patent: 9834598 (1998-08-01), None
patent: 9843630 (1998-10-01), None
patent: 9901467 (1999-01-01), None
patent: 9925359 (1999-05-01), None
patent: 9932089 (1999-07-01), None
patent: 0016814 (2000-03-01), None
patent: 0033892 (2000-06-01), None
patent: 0038811 (2000-06-01), None
patent: 0057401 (2000-08-01), None
patent: 0104118 (2001-01-01), None
patent: 0115744 (2001-03-01), None
patent: 0120331 (2001-03-01), None
patent: 0154664 (2001-06-01), None
patent: 0162722 (2001-08-01), None
patent: 0178736 (2001-10-01), None
patent: 0178739 (2001-10-01), None
patent: 0178741 (2001-10-01), None
patent: 0178745 (2001-10-01), None
patent: 0200199 (2002-01-01), None
patent: 0200679 (2002-01-01), None
patent: 02007767 (2002-01-01), None
patent: 02008243 (2002-01-01), None
patent: 0212265 (2002-02-01), None
patent: 0212266 (2002-02-01), None
patent: 02013868 (2002-02-01), None
patent: 0226723 (2002-04-01), None
patent: 02066422 (2002-06-01), None
patent: 02053186 (2002-07-01), None
patent: 02070490 (2002-09-01), None
patent: 02076933 (2002-10-01), None
patent: 02085296 (2002-10-01), None
patent: 02088167 (2002-11-01), None
patent: 02100879 (2002-12-01), None
patent: 03013427 (2003-02-01), None
patent: 03033000 (2003-04-01), None
patent: 03035688 (2003-05-01), None
patent: 03040691 (2003-05-01), None
patent: 03042229 (2003-05-01), None
patent: 03042230 (2003-05-01), None
patent: 872389 (1987-04-01), None
U.S. Appl. No. 09/958,050 filed Oct. 02, 2001.
U.S. Appl. No. 10/066,964 filed Feb. 04, 2001.
U.S. Appl. No. 10/067,010 filed Feb. 04, 2002.
U.S. Appl. No. 10/066,836 filed Feb. 04, 2002.
U.S. Appl. No. 10/200,364 filed Jul. 22, 2002.
U.S. Appl. No. 10/281,735 filed Oct. 28, 2002.
U.S. Appl. No. 10/241,658 filed Sep. 11, 2002.
U.S. Appl. No. 10/066,951 filed Feb. 04, 2002.
Phillipps, G.H., et al., “Synthesis and Structure-Activity Relationships in a series of Antiinflammatory Corticosteroid Analogues, Halomethyl Androstane-17β-carbothioates and 17β-carboselenoates,” Journal of Medicinal Chemistry 1994, 37, 3717-3729.
Knobil, K., et al., “Adding Salmeterol is More Effective Than Increasing the Dose of Fluticasone for Patients with Asthma who are Symptomatic on Low Dose Fluticasone,” European Respiratory Review, Copenhagen, DK, vol. 12, No. SUPPL 29, Dec. 1998 pp. 19S-20S, XP000992769.
Shapiro E.L., et al., “I7 Heteroaroyl Esters of Corticosteroids 2. I1-Beta Hydroxy Series,” Journal of Medicinal Chemistry, American Chemical Society; Washington, US; vol. 30, No. 9, 1987, pp. 1581-1588, XP002153839.
Janette M. Mahoney et al., “Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea” Current Eye Research, vol. 4, No. 5, 1985, pp. 531-535.
Richard A. Kenley et al., “An Automated, Column-Switching HPLC Method for Analyzing Active and Excipient Materials in Both Cream and Ointment Formulations,” Drug Development and Industrial Pharmacy, vol. 11 (9&10), 1985, pp. 1781-1796.
R. Woodford et al., “Activity and bioavailability of a new steroid (Timobesone acetate) in cream and ointment compared with Lidex and Dermovate creams and ointments and Betnovate cream” Int'l Journal of Pharmaceutics, vol. 26 (1985) pp. 145-155.
Denis J. Kertesz et al., “Thiol Esters from Steroid 17β-Carboxylic Acids: Carboxylate Activation and Internal Participation by 17 α-Acylates” J. Org Chem., vol. 51, 1986, pp. 2315-2328.
Popper , T.L., et al., “ Structure-Activity Relationship of a series of novel topical corticosteroids”, Journal of Steroid Biochemistry 1987, 837-843.
John T. H. Ong et al., “Micellar Solubiliaation of Timobesone Acetate in Aqueous and Aqueous Propylene Glycol Solutions of Nonionic Surfactants”, Pharmaceutical Research, vol. 5, No. 11, 1988, pp. 704-708.
John T. H. Ong et al., Intrinsic Potencies of Novel Thiol Ester Corticosteroids RS-85095 and RS-21314 as Compared With Clobetasol 17-Propionate and Fluocinonide Arch Dermatol, vol. 125, Dec. 1989, pp. 1662-1665.
Isogai, Mitsutaka, et al., “Binding affinities of Mometasone Furoate and related compounds including its Metabolites for the Glucocorticoid Receptor of Rat Skin Tissue” J. Steroid Biochem. Mol. Biol. 1993, 141-145.
S.J. Lane et al., “Evaluation of a New Capillary Electrochromatography/Mass Spectrometry Interface Using Short Columns and High Field Strengths for Rapid and Efficient Analyses,” Rapid Communications in Mass Spectrometry, vol. 10, 1996, pp. 733-736.
Franklin I. Aigbirhio et al., “Automated Radiosynthesis of No-carrier-added [S-fluoromethyl-18F]Fluticasone Propionate as a Radiotracer for Lung Deposition Studies with PET” Journal of Labelled Compounds and Radiopharmaceuticals, vol. 39, No. 7, 1997, pp. 569-584.
Nisha Mistry et al., “Characterisation of impurities in bulk drug batches of fluticasone propionate using directly coupled HPLC-NMR spectroscopy and HPLC-MS,” Journal of Pharmaceutical and Biomedical Analysis vol. 16, 1997, pp. 6
Biggadike Keith
Buxton Ian Richard
Reed Kenton Lewis
Sayani Amyn Pyarali
Badio Barbara P.
Riek James P.
SmithKline Beecham Corporation
LandOfFree
Formulation containing anti-inflammatory androstane derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulation containing anti-inflammatory androstane derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation containing anti-inflammatory androstane derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3497611